Post-Operative Pain Management Share Current And Future Trends And Forecast 2028

Market Overview

The global Post Operative Pain Management Market Share was analyzed by Market Research Future (MRFR) and it was projected that a decent CAGR of 5.4% will be attained by the market over the forecast period of 2017 to 2023. The valuation of the post-operative pain management market was further stated to surpass its previous valuation.

The growing prevalence of diseases across the globe that need surgical forms of treatment and the rising developments of various new drugs for pain relief are expected to be two of the most important factors driving the global post-operative pain management market. The importance of offering effective pain management post operation period with little to no side effects is prompting players to spend considerable time and money in research and development activities to bring forward new solutions. This is, in turn, expanding the market scope and ensuring the growth of the global market. Prevalence of chronic diseases has especially been a key factor accelerating the growth of the market. Chronic diseases like renal diseases, cancer, cardiovascular diseases, and others are some common examples. The increasing geriatric population is additionally influencing a positive demand for the post-operative pain management market. In the coming years, the increasing research and development activities will see the introduction of various highly-effective medications that will subsequently impact the global market in a positive manner.

However, on the other side, complications linked with the overdose of these pain management drugs and the lack of proper healthcare services in some underdeveloped regions are most likely to hamper the growth of the post-operative pain management market in the forthcoming years of the forecast period.

Regional Analysis

The global post-operative pain management market is geographically distributed across the following key regions: Asia Pacific, Americas, Europe, and the Middle East and Africa.

Americas lead the global market of post-operative pain management with the maximum share percentage. This is due to the massive patient pool available in the region that is undergoing surgical procedures and the presence of an established healthcare infrastructure herein.

The European region stands second in the post-operative pain management market and is expected to retain its positioning in the coming years. This is due to the rising research and development activities being undertaken herein to introduce and manufacture new drugs that have fewer side-effects.

The Asia Pacific regional market is anticipated to have the fastest leap over the forecast period. This is due to the widespread prevalence of chronic diseases that need surgical treatment and a fast-paced rise in the geriatric population in Asia Pacific.

Lastly, the Middle East and Africa region is forecasted to have minimal growth in the post-operative pain management market over the forecast period. This is due to the lack of awareness concerning this management methodology and poor primary healthcare services.

Market Segmentation

The global post surgical pain management market has been segmented in terms of pain type, product, application, and target area.

By pain type, the market segments into severe pain, moderate pain, and acute pain.

By product, the market includes antiepileptic drugs, non-steroidal anti-inflammatory drugs (NSAIDs), opioids, COX-2 inhibitors, and other analgesics.

By application, the market divides into migraine, cancer pain, neuropathic pain, arthritic pain, musculoskeletal pain, and others.

By target area, the market branches into legs, back, arms and hand, and others.


Competitive Landscape

The global post-operative pain management market comprises a host of key players. This includes names like F. Hoffmann-La Roche Ltd. (Switzerland), Teva Pharmaceutical Industries Ltd. (Israel), Eli Lilly (U.S), Pfizer (U.S), Baxter International Inc. (US), Johnson Johnson (U.S), Purdue Pharma (U.S), GlaxoSmithKline Plc. (UK), Forest Laboratories Inc. (U.S), Endo Pharmaceuticals Plc. (U.S), Valeant Pharmaceuticals International Inc. (Canada)

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071


Leave a Reply

Your email address will not be published. Required fields are marked *